Investment analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the stock.
China Pharma Trading Down 7.8 %
Shares of CPHI opened at $0.18 on Thursday. China Pharma has a twelve month low of $0.17 and a twelve month high of $1.16. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24. The firm has a fifty day simple moving average of $0.23 and a two-hundred day simple moving average of $0.25.
China Pharma (NYSE:CPHI – Get Free Report) last posted its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $0.93 million during the quarter. China Pharma had a negative return on equity of 61.46% and a negative net margin of 85.56%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Read More
- Five stocks we like better than China Pharma
- ESG Stocks, What Investors Should Know
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Top-Performing Non-Leveraged ETFs This Year
- 5 discounted opportunities for dividend growth investors
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
